Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Vukusic

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
La Revue Du Praticien|December 12, 2012
[New therapies in multiple sclerosis]Stéphanie Roggerone, Florian Chenevier, Christian Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Christian Confavreux (1949 - 2013)Brian G Weinshenker, Sandra Vukusic, Michel G Clanet
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2007
Regional variations in the prevalence of multiple sclerosis in French farmersSandra Vukusic, Vincent Van Bockstael, Sophie Gosselin, et al.
Clinical Neurology and Neurosurgery|December 26, 2012
Myopathic camptocormia associated with myasthenia gravisPerrine Devic, Ariane Choumert, Sandra Vukusic, et al.
European Journal of Neurology|May 26, 2022
Disability Progression in Multiple Sclerosis Patients using Early First-line TreatmentsMathilde Lefort, Sandra Vukusic, Romain Casey, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implicationsRomain Marignier, Pascale Giraudon, Sandra Vukusic, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 3, 2010
Unusual monocular pendular nystagmus in multiple sclerosisLaurence Jasse, Alain Vighetto, Sandra Vukusic, et al.
Annals of Neurology|August 25, 2016
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy riskRomain Marignier, Françoise Durand-Dubief, Renaud du Pasquier, et al.
Pharmacoepidemiology and Drug Safety|October 20, 2020
Long-term effect of first-line injectable multiple sclerosis treatments: Input of a time-dependent propensity scoreMathilde Lefort, Yohann Foucher, Remi Lenain, et al.
Statistics in Medicine|March 5, 2025
Causal Inference in Presence of Intra-Patient Correlation due to Repeated Measurements of Exposure and Outcome in Longitudinal SettingsAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
La Revue Du Praticien|December 12, 2012
[New therapies in multiple sclerosis]Stéphanie Roggerone, Florian Chenevier, Christian Confavreux, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 27, 2013
Christian Confavreux (1949 - 2013)Brian G Weinshenker, Sandra Vukusic, Michel G Clanet
Journal of Neurology, Neurosurgery, and Psychiatry|February 15, 2007
Regional variations in the prevalence of multiple sclerosis in French farmersSandra Vukusic, Vincent Van Bockstael, Sophie Gosselin, et al.
Clinical Neurology and Neurosurgery|December 26, 2012
Myopathic camptocormia associated with myasthenia gravisPerrine Devic, Ariane Choumert, Sandra Vukusic, et al.
European Journal of Neurology|May 26, 2022
Disability Progression in Multiple Sclerosis Patients using Early First-line TreatmentsMathilde Lefort, Sandra Vukusic, Romain Casey, et al.
Therapeutic Advances in Neurological Disorders|December 24, 2010
Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implicationsRomain Marignier, Pascale Giraudon, Sandra Vukusic, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|December 3, 2010
Unusual monocular pendular nystagmus in multiple sclerosisLaurence Jasse, Alain Vighetto, Sandra Vukusic, et al.
Annals of Neurology|August 25, 2016
Rituximab versus fingolimod after natalizumab in multiple sclerosis: Also consider progressive multifocal leukoencephalopathy riskRomain Marignier, Françoise Durand-Dubief, Renaud du Pasquier, et al.
Pharmacoepidemiology and Drug Safety|October 20, 2020
Long-term effect of first-line injectable multiple sclerosis treatments: Input of a time-dependent propensity scoreMathilde Lefort, Yohann Foucher, Remi Lenain, et al.
Statistics in Medicine|March 5, 2025
Causal Inference in Presence of Intra-Patient Correlation due to Repeated Measurements of Exposure and Outcome in Longitudinal SettingsAntoine Gavoille, Fabien Rollot, Romain Casey, et al.
Pageof 23